Streetwise Reports' Article Archives — Current Month (10)
AI Healthcare Stock Showing Signs of a Base Breakout (08/25/2025)
John Newell of John Newell & Associates explains why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.
Cleantech Co. Advances Innovative Systems for Data Centers (08/19/2025)
Environmental and cleantech company BioLargo Inc. (BLGO:OTCQX) announces its financial results, including a huge increase in revenue in its engineering segment due to contracts to provide control compliance services.
Co.'s Graphene Used in New Screening Test for Lung Cancer (08/18/2025)
HydroGraph Clean Power Inc.'s (HG:CSE; HGRAF:OTCQB; M98:FSE) patented, high-purity material has applications in healthcare, as in this case, but also in numerous other industries. Read on to learn why some experts say this company could be a future 100-bagger.
AI Biotech Company Plans Saudi Venture to Develop Cancer Drug (08/14/2025)
Rakovina Therapeutics Inc. (RKV:TSX.V) has signed a Letter of Intent with NanoPalm to co-develop AI-discovered cancer treatments starting with kt-3283. Read how the experimental drug targets hard-to-treat tumors and may signal a broader pipeline to come
Medical Co.'s New Joint Venture Could Expand Co.'s Footprint (08/13/2025)
Leede Financial Inc. analyst Dr. Douglas Loe gave this company a Buy rating.
Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada (08/11/2025)
Top-line results from Cardiol Therapeutics' (CRDL:TSX; CRDL:NASDAQ) ARCHER study for Acute Myocarditis are quite promising, writes Roth Capital Partners Analyst Jason Wittes in an updated research note.
Biotech Announces Topline Results From Cardiovascular Drug Trial (08/11/2025)
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) Analyst Brandon Folkes reviews Cardiol Therapeutics Inc. after it announced the topline results from its Phase II ARCHER trial of CardiolRx in acute myocarditis.
Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment (08/11/2025)
Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announces topline results from its Phase II clinical study involving patients with acute myocarditis. Read why analysts like this pharmaceutical stock.
Canadian Pharma Finds Promising Cardiovascular Breakthrough (08/08/2025)
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) reports headline Phase II data from its 109-patient acute myocarditis study, known as the ARCHER trial. Read to see how one analyst rates the stock.
Cleantech/Life Sciences Co. Advances Products in Q2/25 (08/04/2025)
BioLargo Inc. (BLGO:OTCQX) enters into several agreements, forms partnerships and receives third party product validation, noted an Oak Ridge Financial report.
More Archives
2025Jul Jun May Apr Mar Feb Jan
2024Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
